Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Add AP News on Google Add AP News as your ...
In a phase 1–2 trial, teclistamab, a bispecific antibody targeting CD3 on T-cell surfaces and B-cell maturation antigen on myeloma cells, showed durable responses in heavily pretreated patients with ...
Appium version: 2.10.1 Selenium version: 4.10.0 Desktop OS/version used to run Appium: Mac OS Ventura 13.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results